1 – 20 of 25
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
ABO Genotyping finds more A2 to B kidney transplant opportunities than lectin-based subtyping
(
- Contribution to journal › Article
- 2022
-
Mark
Longevity of anti-spike and anti-nucleocapsid antibodies after COVID-19 in solid organ transplant recipients compared to immunocompetent controls
(
- Contribution to journal › Article
- 2021
-
Mark
COVID-19 in solid organ transplant recipients : A national cohort study from Sweden
(
- Contribution to journal › Article
- 2018
-
Mark
Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients
(
- Contribution to journal › Article
-
Mark
Heparin-binding protein, lysozyme, and inflammatory cytokines in bronchoalveolar lavage fluid as diagnostic tools for pulmonary infection in lung transplanted patients
(
- Contribution to journal › Article
- 2016
-
Mark
Altered Immunogenicity of Donor Lungs via Removal of Passenger Leukocytes Using Ex Vivo Lung Perfusion.
(
- Contribution to journal › Article
-
Mark
Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Three-Year Results From the Randomized SCHEDULE Study.
(
- Contribution to journal › Article
- 2015
-
Mark
The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial
(
- Contribution to journal › Article
-
Mark
Genetic variation in caveolin-1 correlates with long-term pancreas transplant function
(
- Contribution to journal › Article
- 2014
-
Mark
Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal in Heart Transplant Recipients: A Randomized Trial
(
- Contribution to journal › Article
- 2013
-
Mark
Tacrolimus Predose Concentrations Do Not Predict the Risk of Acute Rejection After Renal Transplantation: A Pooled Analysis From Three Randomized-Controlled Clinical Trials
(
- Contribution to journal › Article
- 2012
-
Mark
Virtual Histology Assessment of Cardiac Allograft Vasculopathy Following Introduction of Everolimus-Results of a Multicenter Trial.
(
- Contribution to journal › Article
-
Mark
Influence of HLA Matching on Heart Transplant Outcomes
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo
(
- Contribution to journal › Article
- 2011
-
Mark
Time trends in risk and risk determinants of non-Hodgkin lymphoma in solid organ transplant recipients
(
- Contribution to journal › Article
-
Mark
Pediatric organ transplantation and risk of premalignant and malignant tumors in Sweden
(
- Contribution to journal › Debate/Note/Editorial
- 2010
-
Mark
Is Rituximab Safe to Use in Kidney Transplant Patients?
(
- Contribution to journal › Letter
- 2009
-
Mark
Subgroup Analyses in Randomized Controlled Trials: The Need for Risk Stratification in Kidney Transplantation
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Calcineurin Inhibitor Minimization in the Symphony Study: Observational Results 3 Years after Transplantation.
(
- Contribution to journal › Article
- 2008
-
Mark
Can DXA Predict Fractures in Renal Transplant Patients?
(
- Contribution to journal › Article